In explaining the rationale behind the study, Tang and colleagues pointed out that despite the lack of level 1 evidence, MDT ...

Cancer remains one of the leading causes of illness and death worldwide, and cases are expected to rise over the next decade, ...

Dr. Omer Awan, physician and public health expert, breaks down the latest data as well as health disparities associated with ...

NHS patients will be told their real-time cancer risk with the help of gadgets such as smartwatches. Everyone will be able to access “real-time personalised insights about their cancer risk” within a ...

Providing clinicians with access to patient-reported outcome data improves the inter-rater reliability and consistency of ...

The study added to a large existing volume of evidence that has consistently shown a risk-reducing effect of OBS on ovarian cancer, said Karen H. Lu, MD, of Moffitt Cancer Center in Tampa, Florida and ...

The FDA granted Breakthrough Therapy status to zovegalisib plus Faslodex for patients with PIK3CA-mutated HR+/HER2- advanced breast cancer. The U.S. Food and Drug Administration (FDA) has granted ...

Despite major advances in genetic testing for breast cancer risk prediction, death rates remain disproportionately high among ...

Inside the NHS cancer crisis as senior doctors warn of treatment ‘disaster’ - SPECIAL REPORT: The NHS can offer more treatments for cancer than ever before, but clinicians warn that staff shortages ...

Page and Fremont county residents have an opportunity to learn more about local cancer data and resources next week.

Cancer treatment in India is becoming increasingly expensive, with prolonged treatment periods adding to the financial burden ...